Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)

Q: What does CUSIP 71722W107 represent in this 13F holders report?

CUSIP 71722W107 is the security identifier for PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q2 2021?

76 institutional investors reported PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q2 2021. Use the holders table for investor-level position and value details.

CUSIP: 71722W107

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 78,837,943
Total 13F shares: 24,918,954
Share change: +438,588
Total reported value: $843,508,479
Price per share: $33.85
Number of holders: 76
Value change: +$13,169,188
Number of buys: 43
Number of sells: 31

Quarterly Holders Quick Answers

What is CUSIP 71722W107?
CUSIP 71722W107 identifies PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 71722W107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FRAZIER MANAGEMENT LLC	13F	Company	7.4%	5,827,415	$218,878,000	—	31 Mar 2021	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	4%	3,115,008	$117,000,000	—	31 Mar 2021	13F
Medicxi Ventures Management (Jersey) Ltd	13F	Company	2.6%	2,067,861	$77,669,000	—	31 Mar 2021	13F
Invesco Ltd.	13F	Company	2.6%	2,028,931	$76,208,000	—	31 Mar 2021	13F
JANUS HENDERSON GROUP PLC	13F	Company	2.5%	1,954,448	$73,414,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	1.9%	1,479,592	$55,573,000	—	31 Mar 2021	13F
Ensign Peak Advisors, Inc	13F	Company	1.6%	1,239,462	$46,553,000	—	31 Mar 2021	13F
Abingworth LLP	13F	Company	1.5%	1,203,135	$45,057,000	—	31 Mar 2021	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	1%	818,385	$30,739,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	1%	815,940	$30,647,000	—	31 Mar 2021	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.76%	600,000	$22,536,000	—	31 Mar 2021	13F
Greenspring Associates, LLC	13F	Company	0.46%	360,939	$13,557,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	0.42%	329,343	$12,370,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	0.28%	217,198	$8,158,000	—	31 Mar 2021	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.27%	210,973	$7,924,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.27%	209,508	$7,869,000	—	31 Mar 2021	13F
GW&K Investment Management, LLC	13F	Company	0.25%	199,518	$7,494,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.25%	194,374	$7,300,000	—	31 Mar 2021	13F
Rhenman & Partners Asset Management AB	13F	Company	0.22%	175,000	$6,573,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.17%	131,856	$4,952,000	—	31 Mar 2021	13F
MARSHALL WACE, LLP	13F	Company	0.14%	113,885	$4,278,000	—	31 Mar 2021	13F
Ikarian Capital, LLC	13F	Company	0.13%	100,000	$3,757,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.11%	87,256	$3,278,000	—	31 Mar 2021	13F
Penn Mutual Asset Management	13F	Company	0.11%	86,940	$3,265,000	—	31 Mar 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.1%	81,600	$3,065,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.08%	65,956	$2,477,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.08%	65,003	$2,442,000	—	31 Mar 2021	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.08%	63,772	$2,395,000	—	31 Mar 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.07%	54,655	$2,053,000	—	31 Mar 2021	13F
Woodline Partners LP	13F	Company	0.05%	41,678	$1,565,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.05%	41,222	$1,548,000	—	31 Mar 2021	13F
Marshall Wace North America L.P.	13F	Company	0.05%	37,530	$1,411,000	—	31 Mar 2021	13F
Summit Rock Advisors, LP	13F	Company	0.04%	34,100	$1,281,000	—	31 Mar 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.04%	31,400	$1,179,000	—	31 Mar 2021	13F
Parkman Healthcare Partners LLC	13F	Company	0.04%	30,207	$1,135,000	—	31 Mar 2021	13F
AVIVA PLC	13F	Company	0.04%	29,463	$1,107,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.04%	29,400	$1,104,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.03%	26,505	$996,000	—	31 Mar 2021	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.03%	20,000	$751,000	—	31 Mar 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	17,463	$656,000	—	31 Mar 2021	13F
Swiss National Bank	13F	Company	0.02%	16,600	$623,000	—	31 Mar 2021	13F
Cambridge Investment Research Advisors, Inc.	13F	Company	0.02%	16,300	$612,000	—	31 Mar 2021	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.02%	14,900	$560,000	—	31 Mar 2021	13F
Occidental Asset Management, LLC	13F	Company	0.02%	12,872	$483,000	—	31 Mar 2021	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.02%	12,592	$473,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.02%	12,090	$454,000	—	31 Mar 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	11,390	$428,000	—	31 Mar 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.01%	11,300	$424,000	—	31 Mar 2021	13F
Squarepoint Ops LLC	13F	Company	0.01%	11,186	$420,000	—	31 Mar 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.01%	10,500	$394,000	—	31 Mar 2021	13F

Institutional Holders of Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) as of Q2 2021

As of 30 Jun 2021, Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,918,954 shares. The largest 10 holders included FRAZIER MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P., Medicxi Ventures Management (Jersey) Ltd, Invesco Ltd., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, Ensign Peak Advisors, Inc, Abingworth LLP, BlackRock Inc., and EVENTIDE ASSET MANAGEMENT, LLC. This page lists 77 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

-6

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.